Barbara Ambrose joined CAS in 1986 while earning her Ph.D. from the Ohio State University for work on DNA sequencing. She currently curates journal documents and patents in molecular genetics for the Life Sciences Department at CAS. In March 2020, she joined the Coronavirus Task Force established at CAS to expedite processing COVID-19-related journal articles and information. She is a 34-year member of the American Chemical Society and Secretary of the ACS Columbus Local Section.
Latest Content from Barbara Ambrose
April 12, 2021
Novel oligonucleotide with application in mRNA vaccine quality control gets 250 millionth CAS Registry Number
Novel oligonucleotide from Moderna, with application in mRNA vaccine quality control, marks the 250 millionth substance registration in CAS REGISTRY.